메뉴 건너뛰기
Seminars in Oncology
Volumn 33, Issue SUPPL. 11, 2006, Pages 33-35
Optimum Use of Biologics and Role of Maintenance Therapy in Colon Cancer
Author keywords

[No Author keywords available]
Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BIOLOGIC AGENT; CANCER VACCINE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FLUOROURACIL; FOLINIC ACID; IMATINIB; IMMUNOLOGIC AGENT; IRINOTECAN; MERCAPTOPURINE; METHOTREXATE; OXALIPLATIN; TRASTUZUMAB; UFT;
EID: 33845451091     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.10.008     Document Type: Article
Times cited : (3)
References (8)
  • 1
    • 2542561964 scopus 로고    scopus 로고
    • Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    • Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
    • (2004) N Engl J Med , vol.350 , pp. 2335-2342
    • Hurwitz, H.1    Fehrenbacher, L.2    Novotny, W.3
  • 2
    • 21244475037 scopus 로고    scopus 로고
    • Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) vs cetuximab/bevacizumab (CB) in irinotecan refractory colorectal cancer
    • (abstr 3508)
    • Saltz L.B., Lenz H.-J., Hochster H., et al. Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) vs cetuximab/bevacizumab (CB) in irinotecan refractory colorectal cancer. Proc Am Soc Clin Oncol 23 (2005) 248s (abstr 3508)
    • (2005) Proc Am Soc Clin Oncol , vol.23
    • Saltz, L.B.1    Lenz, H.-J.2    Hochster, H.3
  • 3
    • 21244481589 scopus 로고    scopus 로고
    • High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer
    • Results from the Eastern Cooperative Oncology Group (ECOG) study E3200 (abstr 2)
    • Giantonio B.J., Catalano P.J., Meropol N.J., et al., Results from the Eastern Cooperative Oncology Group (ECOG) study E3200. High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer. J Clin Oncol 23 suppl (2005) 1 (abstr 2)
    • (2005) J Clin Oncol , vol.23 , Issue.SUPPL , pp. 1
    • Giantonio, B.J.1    Catalano, P.J.2    Meropol, N.J.3
  • 4
    • 3242720345 scopus 로고    scopus 로고
    • Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    • Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004) 337-345
    • (2004) N Engl J Med , vol.351 , pp. 337-345
    • Cunningham, D.1    Humblet, Y.2    Siena, S.3
  • 5
    • 0021867923 scopus 로고
    • Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection
    • Kaiser M., and Ellenberg S. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120 (1985) 899-903
    • (1985) Arch Surg , vol.120 , pp. 899-903
    • Kaiser, M.1    Ellenberg, S.2
  • 6
    • 16544369867 scopus 로고    scopus 로고
    • A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung (Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy)
    • Kato K., Ichinose Y., Ohta M., et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung (Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy). N Engl J Med 350 (2004) 1713-1721
    • (2004) N Engl J Med , vol.350 , pp. 1713-1721
    • Kato, K.1    Ichinose, Y.2    Ohta, M.3
  • 7
    • 21244462421 scopus 로고    scopus 로고
    • Adjuvant therapy for colon cancer - The pace quickens
    • Allegra C., and Sargent D.J. Adjuvant therapy for colon cancer - The pace quickens. N Engl J Med 352 (2005) 2746-2748
    • (2005) N Engl J Med , vol.352 , pp. 2746-2748
    • Allegra, C.1    Sargent, D.J.2
  • 8
    • 4444324751 scopus 로고    scopus 로고
    • Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer
    • Maindrault-Goebel F., Tournigand C., Andre T., et al. Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer. Ann Oncol 15 (2004) 1210-1214
    • (2004) Ann Oncol , vol.15 , pp. 1210-1214
    • Maindrault-Goebel, F.1    Tournigand, C.2    Andre, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.